Search Login Register

2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine (SKF 38393) Summary

Description: A selective D1 dopamine receptor agonist used primarily as a research tool.

Also Known As: SKF 38393; 1H-3-Benzazepine-7,8-diol, 2,3,4,5-tetrahydro-1-phenyl-; R-SK&F 38393; SK&F-38393; SKF 38393-A Show All >>

Networked: 151 relevant articles (8 outcomes, 7 trials/studies) for this Bio-Agent

Key Diseases for which 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine is Relevant

  1. Obesity : 1 outcome 1 study in 2 results
  2. Catalepsy : 1 outcome in 12 results
  3. Hypothermia : 1 outcome in 7 results
  4. Movement Disorders (Movement Disorder) : 1 outcome in 6 results
  5. Self Mutilation : 1 outcome in 4 results
Show All >>

Drugs Related to 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine

  1. Bromocriptine (Parlodel)
  2. Quinpirole
  3. Dopamine Agonists (Dopamine Agonist)
  4. Apomorphine
  5. Dopamine (Intropin)
  6. Levodopa (L Dopa)
  7. Dopamine D2 Receptors (Dopamine D2 Receptor)
  8. Adenosine
  9. 2-Chloroadenosine (2 Chloroadenosine)
  10. 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
Show All >>

Therapies Related to 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine

  1. Injections
  2. Ligation
  3. Transplants (Transplant)
  4. Induced Hyperthermia (Thermotherapy)
  5. Aftercare (After-Treatment)

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.